학술논문

The efficacy of tobacco cessation treatment for African American adults: a systematic review
Document Type
Academic Journal
Source
Translational Behavioral Medicine. October 2023, Vol. 13 Issue 10, p775, 9 p.
Subject
Care and treatment
Analysis
Development and progression
Research
Evidence-based medicine -- Analysis -- Research
Substance abuse treatment -- Analysis -- Research
African Americans -- Analysis -- Research
Disease susceptibility -- Research -- Development and progression -- Care and treatment
Online searching -- Analysis -- Research
Smoking cessation -- Research -- Analysis
Varenicline -- Research
Adults -- Research -- Analysis
Database searching -- Analysis -- Research
Internet/Web search services -- Analysis -- Research
Smoking cessation programs -- Research -- Analysis
Substance abuse -- Care and treatment
Language
English
ISSN
1869-6716
Abstract
Tobacco use remains the leading cause of preventable disease, disability, and death in the USA; and inflicts a tremendous health burden on its users, leading to disease and disability in [...]
Despite proliferation of evidence-based tobacco cessation treatments, African American adults still suffer higher rates of tobacco-related diseases than White adults. Although tobacco cessation treatment is efficacious, there is a need to reassess the efficacy of tobacco cessation treatment for African American adults. Previous reviews of tobacco cessation treatment studies conducted through 2007 among African American adults highlight the limited research in this area and inconsistent findings on treatment characteristics impacting efficacy.This systematic review examined the efficacy of combined behavioral and pharmacological tobacco cessation treatment for African American adults. Database searches were used to identify studies examining tobacco cessation treatment for predominantly African American samples (>50%). Eligible studies were completed between 2007 and 2021 and (i) involved randomization comparing active combined treatment to a control comparison group and (ii) reported abstinence outcomes at 6 and/or 12 months. Ten studies met inclusion criteria. Active treatment groups typically consisted of a combination of nicotine replacement therapy and behavioral counseling. Abstinence rates for African American adults ranged from 10.0% to 34% in active treatment groups compared to 0.0%-40% in comparison control groups. Our results support the efficacy of combined treatment for tobacco cessation among African American adults. However, cessation rates for African American adults found in this review are lower than those in the general adult population (15%--88%). Additionally, our findings highlight the limited number of studies examining African American tobacco cessation rates and testing of tailored treatment for this population. African American adults are more likely to develop disease when using tobacco products than other adults. Previous reviews of literature assessng tobacco cessation treatment have been conducted on research until 2007 Therefore, we assessed how well tobacco cessation treatments that were tested 2007-2021 work to decrease tobacco use for this population. We found that 10 studies tested tobacco cessation treatment with majority African American participants, in comparison to more standard treatment. Overall, tobacco cessation treatment that combines behavioral and pharmacological approaches decreases tobacco use for African American adults. However, quit rates among African American adults are lower than those found in the general population. Our findings indicate that very few studies have focused on African American adult tobacco cessation treatment outcomes, which has potentially contributed to health inequity. Keywords Tobacco cessation treatment, African American adults, Treatment efficacy, Systematic review